Triumpharma Inc. is a pioneer in developing systems and solutions for advanced drug delivery. We strive to bridge the gap between life science and modern healthcare.

Triumpharma Inc. develops technologies that enhance the performance of many of today's commonly available pharmaceutical products and new chemical entities that give raise to challenging bioavailability problems.

Triumpharma has strong technical capabilities to take products from feasibility to pilot scale. Triumpharma conducts formulation optimization studies, pre-clinical trials on animals, human clinical studies including bioavailability/ bioequivalence trial complying with the international guidelines. The company's core advantages are its extremely low-cost base, experienced staff with multi national experience, holding PhDs from western universities, high-quality research, a large pool of patient’s and volunteers, and fast formulation development meeting the necessary regulatory requirements.

Clinical Development Services

  •   Phase I for Pharma/Biotech Companies
  •   BE/BA Studies for Generic Drug Companies
  •   Clinical Trials Phases , II, III, IV
  •   Manufacturing of clinical trials supplies (GMP pilot facility)
  •   A regional network of sites capable of running clinical trials
  •   Pre Clinical evaluation

 

Clinical Development Services

 Phase I for Pharma/Biotech Companies

  •  BE/BA Studies for Generic Drug Companies
  •  Clinical Trials Phases , II, III, IV
  •  Manufacturing of clinical trials supplies (GMP pilot facility)
  • A regional network of sites capable of running clinical trials
  • Pre Clinical evaluation

 

Triumpharma Inc. is a pioneer in developing systems and solutions for advanced drug delivery.

Triumpharma Inc. develops technologies that enhance the performance of many of today's commonly available pharmaceutical products and new chemical entities that give raise to challenging bioavailability problems.

We have strong technical capabilities to take products from feasibility to pilot scale. Triumpharma conducts formulation optimization studies, pre clinical trials on animals, human clinical studies including bioavailability/ bioequivalence trial complying with the international guidelines.

The company's core advantages are its extremely low-cost base, experienced staff with multi national experience, holding PhDs from western universities, high-quality research, a large pool of patient's and volunteers, and fast formulation development meeting the necessary regulatory requirements.

 

 

This publication has been produced with the assistance of the European Union in cooperation with Jordan Enterprise Development Corporation. *

* The contents of this publication are the sole responsibility of Triumpharma and can in no way betaken to reflect the views of the European Union & Jordan Enterprise Development Corporation